Table 1 Projected 95% confidence intervals for the prevalence of clinical reactivity in peanut allergic children and adults receiving the ED 05 dose (6 mg of whole peanut = 1.5 mg of peanut protein) for sample sizes ranging from 70 to 200
Sample size (of peanut allergic individuals) | Value of target prevalence (5% for the ED05) | Projected 95% confidence interval |
|---|---|---|
70 | 5% | 0.9% - 12% |
100 | 5% | 1.6% - 11% |
150 | 5% | 2.3% - 10% |
200 | 5% | 2.4% - 9% |
375 | 5% | 3.1% - 7.8% |